Journal Article Summary
The article investigates the effects of suvorexant, an orexin receptor antagonist, on sleep patterns in both healthy individuals and patients suffering from primary insomnia. Understanding how suvorexant influences sleep is important because insomnia can significantly impact a person's quality of life, and effective treatments are needed. By comparing the electroencephalographic (EEG) power spectral density (PSD) profiles of suvorexant with those of a placebo and other insomnia medications, the study aims to shed light on how this drug works in the brain during sleep.
In this study, researchers conducted a phase 2 trial involving 229 patients with insomnia and 124 healthy subjects. Participants received different doses of suvorexant or a placebo over two periods, with sleep monitored in sleep laboratories. The results showed that the PSD profiles of suvorexant at various doses during both non-rapid eye movement (NREM) and rapid eye movement (REM) sleep were similar to those of the placebo, indicating limited effects on sleep neurophysiology. In contrast, other insomnia medications displayed distinct EEG profiles, suggesting that suvorexant may improve sleep without significantly altering brain activity.
However, the study has limitations, including the specific population studied and the short duration of the trial. Patients should be aware that while suvorexant may help with sleep, its effects on brain activity are minimal compared to other treatments. It is essential for individuals considering suvorexant to discuss their sleep issues and treatment options with a healthcare professional to ensure the best approach for their specific needs.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ma Junshui, Svetnik Vladimir, Snyder Ellen, Lines Christopher, Roth Thomas, Herring W. Joseph. Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects. Sleep 2014. DOI: 10.5665/sleep.4068. PMID: 25197807. PMCID: PMC4173918.
Featured Pill Pals Product
Trazodone 50 mg Tablets --- Generic For Desyrel --- Zydus
Trazodone 50 mg Tablets — Generic For Desyrel — Zydus is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
